Over the past 12 months, 8 insiders at Kura Oncology, Inc. filed 33 open-market SEC Form 4 transactions on KURA: 3 purchases worth $713K and 30 sales worth $1.9M. Insiders have been net sellers over this period. The most recent filing was on May 19, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 19, 26 | Kathleen FordChief Operating Officer | SELL | 2.3K | $9.08 | $20K |
| May 18, 26 | Teresa Brophy BairChief Legal Officer | SELL | 2.3K | $9.38 | $21K |
| Jan 27, 26 | Teresa Brophy BairChief Legal Officer | SELL | 4.8K | $8.46 | $40K |
| Jan 27, 26 | Francis BurrowsChief Scientific Officer | SELL | 1.3K | $8.46 | $11K |
| Jan 27, 26 | Thomas James DoyleSVP, Finance & Accounting | SELL | 2.2K | $8.46 | $19K |
| Jan 27, 26 | Kathleen FordChief Operating Officer | SELL | 1.8K | $8.46 | $15K |
| Jan 27, 26 | Mollie LeoniChief Medical Officer | SELL | 3.7K | $8.46 | $31K |
| Jan 27, 26 | Brian T. PowlChief Commercial Officer | SELL | 4.8K | $8.46 | $41K |
| Dec 18, 25 | Francis BurrowsChief Scientific Officer | SELL | 23.7K | $9.78 | $232K |
| Dec 9, 25 | Faheem HasnainDirector | SELL | 10.0K | $10.98 | $110K |
| Nov 14, 25 | Teresa Brophy BairChief Legal Officer | SELL | 8.8K | $11.18 | $98K |
| Nov 14, 25 | Thomas James DoyleSVP, Finance & Accounting | SELL | 4.5K | $11.18 | $51K |
| Nov 14, 25 | Kathleen FordChief Operating Officer | SELL | 6.9K | $11.18 | $77K |
| Nov 14, 25 | Mollie LeoniChief Medical Officer | SELL | 15.5K | $11.18 | $173K |
| Nov 14, 25 | Brian T. PowlChief Commercial Officer | SELL | 8.9K | $11.18 | $99K |
| Sep 29, 25 | Teresa Brophy BairChief Legal Officer | SELL | 8.8K | $8.94 | $79K |
| Sep 29, 25 | Thomas James DoyleSVP, Finance & Accounting | SELL | 4.5K | $8.94 | $41K |
| Sep 29, 25 | Kathleen FordChief Operating Officer | SELL | 6.9K | $8.94 | $62K |
| Sep 29, 25 | Mollie LeoniChief Medical Officer | SELL | 12.3K | $8.94 | $110K |
| Sep 29, 25 | Brian T. PowlChief Commercial Officer | SELL | 8.9K | $8.94 | $79K |
| Sep 29, 25 | Troy Edward WilsonPresident and CEO | SELL | 36.6K | $8.94 | $327K |
| Sep 8, 25 | Troy Edward WilsonPresident & CEO | BUY | 50.0K | $8.20 | $410K |
| Aug 13, 25 | Troy Edward WilsonPresident and CEO | BUY | 13.5K | $6.64 | $90K |
| Aug 12, 25 | Troy Edward WilsonPresident and CEO | BUY | 36.5K | $5.85 | $214K |
| May 19, 25 | Teresa Brophy BairChief Legal Officer | SELL | 1.6K | $5.96 | $9K |
| May 19, 25 | Kathleen FordChief Operating Officer | SELL | 1.6K | $6.28 | $10K |
| Mar 21, 25 | Faheem HasnainDirector | SELL | 22.7K | $8.00 | $181K |
| Jan 28, 25 | Teresa Brophy BairChief Legal Officer | SELL | 4.8K | $7.87 | $38K |
| Jan 28, 25 | Francis BurrowsChief Scientific Officer | SELL | 1.3K | $7.87 | $10K |
| Jan 28, 25 | Thomas James DoyleSVP, Finance & Accounting | SELL | 2.2K | $7.87 | $18K |
| Jan 28, 25 | Kathleen FordChief Operating Officer | SELL | 1.8K | $7.87 | $14K |
| Jan 28, 25 | Mollie LeoniChief Medical Officer | SELL | 2.3K | $7.87 | $18K |
| Jan 28, 25 | Brian T. PowlChief Commercial Officer | SELL | 1.6K | $7.87 | $12K |
| Nov 18, 24 | Kathleen FordChief Operating Officer | SELL | 526 | $16.03 | $8K |
| May 20, 24 | Teresa Brophy BairChief Legal Officer | SELL | 2.6K | $22.15 | $58K |
| Jan 30, 24 | Stephen DaleChief Medical Officer | SELL | 4.8K | $21.55 | $104K |
| Jan 29, 24 | Teresa Brophy BairChief Legal Officer | SELL | 2.1K | $17.80 | $37K |
| Jan 29, 24 | Stephen DaleChief Medical Officer | SELL | 4.4K | $17.80 | $78K |
| Jan 29, 24 | Thomas James DoyleSVP, Finance & Accounting | SELL | 963 | $17.80 | $17K |
| Jan 29, 24 | Kathleen FordChief Operating Officer | SELL | 1.5K | $17.80 | $27K |
| Jan 24, 24 | Troy Edward WilsonPresident and CEO | SELL | 84.1K | $20.23 | $1.7M |
| Jun 16, 23 | Thomas MalleyDirector | BUY | 50.0K | $11.50 | $575K |
| Jan 27, 23 | Stephen DaleChief Medical Officer | SELL | 4.8K | $13.89 | $67K |
| Jan 27, 23 | Thomas James DoyleSVP, Finance & Accounting | SELL | 866 | $13.89 | $12K |
| Jan 27, 23 | Kirsten FlowersCCO & Chief Strategy Officer | SELL | 1.9K | $13.89 | $26K |
| Jan 27, 23 | Kathleen FordChief Operating Officer | SELL | 1.8K | $13.89 | $25K |
| Nov 17, 22 | Teresa Brophy BairChief Legal Officer | SELL | 2.1K | $15.22 | $32K |
Over the past 12 months, insiders at Kura Oncology, Inc. filed 3 open-market purchases worth $713K and 30 sales worth $1.9M on KURA, which makes them net sellers over the period. The most recent Form 4 was filed on May 19, 26.
The largest recent open-market KURA insider purchase in our data was $575K by Thomas Malley, Director, filed on Jun 16, 23.
8 different insiders at Kura Oncology, Inc. filed open-market SEC Form 4 transactions on KURA over the last 12 months.
InsiderTape plots every KURA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Kura Oncology, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →